{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Synaptogyrines : Questions médicales les plus fréquentes",
"headline": "Synaptogyrines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Synaptogyrines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-06",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Synaptogyrines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de tissu nerveux",
"url": "https://questionsmedicales.fr/mesh/D009419",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de tissu nerveux",
"code": {
"@type": "MedicalCode",
"code": "D009419",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.631"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Synaptogyrines",
"alternateName": "Synaptogyrins",
"code": {
"@type": "MedicalCode",
"code": "D062805",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Lingfei Li",
"url": "https://questionsmedicales.fr/author/Lingfei%20Li",
"affiliation": {
"@type": "Organization",
"name": "Division of Neurology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China."
}
},
{
"@type": "Person",
"name": "Philip Wing-Lok Ho",
"url": "https://questionsmedicales.fr/author/Philip%20Wing-Lok%20Ho",
"affiliation": {
"@type": "Organization",
"name": "Division of Neurology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China."
}
},
{
"@type": "Person",
"name": "Shirley Yin-Yu Pang",
"url": "https://questionsmedicales.fr/author/Shirley%20Yin-Yu%20Pang",
"affiliation": {
"@type": "Organization",
"name": "Division of Neurology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China."
}
},
{
"@type": "Person",
"name": "Zoe Yuen-Kiu Choi",
"url": "https://questionsmedicales.fr/author/Zoe%20Yuen-Kiu%20Choi",
"affiliation": {
"@type": "Organization",
"name": "Division of Neurology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China."
}
},
{
"@type": "Person",
"name": "Yasine Malki",
"url": "https://questionsmedicales.fr/author/Yasine%20Malki",
"affiliation": {
"@type": "Organization",
"name": "Division of Neurology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Remnant cholesterol as a risk factor for all-cause and cardiovascular mortality in incident peritoneal dialysis patients.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36948938",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.numecd.2023.02.009"
}
},
{
"@type": "ScholarlyArticle",
"name": "Anesthetic Care of the Pregnant Patient With Cardiovascular Disease: A Scientific Statement From the American Heart Association.",
"datePublished": "2023-02-13",
"url": "https://questionsmedicales.fr/article/36780370",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1161/CIR.0000000000001121"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inflammation compared to low-density lipoprotein cholesterol: two different causes of atherosclerotic cardiovascular disease.",
"datePublished": "2023-02-01",
"url": "https://questionsmedicales.fr/article/36752631",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MOL.0000000000000867"
}
},
{
"@type": "ScholarlyArticle",
"name": "Two-year changes in body composition and future cardiovascular events: a longitudinal community-based study.",
"datePublished": "2023-01-31",
"url": "https://questionsmedicales.fr/article/36721154",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12986-023-00727-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Individual or familial diabetes in relation to eight cardiovascular diseases: A two-sample Mendelian randomization study.",
"datePublished": "2023-01-29",
"url": "https://questionsmedicales.fr/article/36775708",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.numecd.2023.01.018"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de tissu nerveux",
"item": "https://questionsmedicales.fr/mesh/D009419"
},
{
"@type": "ListItem",
"position": 5,
"name": "Synaptogyrines",
"item": "https://questionsmedicales.fr/mesh/D062805"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Synaptogyrines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Synaptogyrines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Synaptogyrines",
"description": "Comment diagnostiquer une anomalie des synaptogyrines ?\nQuels examens sont utilisés pour évaluer les synaptogyrines ?\nLes tests génétiques sont-ils fiables pour les synaptogyrines ?\nQuels symptômes peuvent indiquer un problème avec les synaptogyrines ?\nPeut-on détecter les synaptogyrines par des analyses sanguines ?",
"url": "https://questionsmedicales.fr/mesh/D062805?mesh_terms=Cardiovascular+System&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Synaptogyrines",
"description": "Quels sont les symptômes associés aux dysfonctionnements des synaptogyrines ?\nLes troubles moteurs sont-ils liés aux synaptogyrines ?\nLes troubles cognitifs peuvent-ils être causés par des anomalies des synaptogyrines ?\nLes convulsions sont-elles fréquentes avec des problèmes de synaptogyrines ?\nPeut-on observer des changements de comportement liés aux synaptogyrines ?",
"url": "https://questionsmedicales.fr/mesh/D062805?mesh_terms=Cardiovascular+System&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Synaptogyrines",
"description": "Peut-on prévenir les troubles liés aux synaptogyrines ?\nLe dépistage précoce est-il important pour les synaptogyrines ?\nLes conseils génétiques sont-ils recommandés pour les familles ?\nY a-t-il des facteurs environnementaux à surveiller ?\nLes vaccinations peuvent-elles prévenir des troubles neurologiques ?",
"url": "https://questionsmedicales.fr/mesh/D062805?mesh_terms=Cardiovascular+System&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Synaptogyrines",
"description": "Quels traitements sont disponibles pour les troubles liés aux synaptogyrines ?\nLa thérapie génique est-elle une option pour les anomalies des synaptogyrines ?\nLes médicaments peuvent-ils améliorer les symptômes liés aux synaptogyrines ?\nDes interventions chirurgicales sont-elles possibles pour ces troubles ?\nLes thérapies physiques sont-elles bénéfiques pour les patients ?",
"url": "https://questionsmedicales.fr/mesh/D062805?mesh_terms=Cardiovascular+System&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Synaptogyrines",
"description": "Quelles complications peuvent survenir avec des troubles des synaptogyrines ?\nLes troubles de l'humeur sont-ils des complications possibles ?\nLes patients peuvent-ils développer des troubles psychiatriques ?\nLes complications peuvent-elles affecter la qualité de vie ?\nY a-t-il un risque accru de mortalité avec ces troubles ?",
"url": "https://questionsmedicales.fr/mesh/D062805?mesh_terms=Cardiovascular+System&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Synaptogyrines",
"description": "Quels sont les facteurs de risque pour les troubles des synaptogyrines ?\nL'hérédité joue-t-elle un rôle dans les troubles des synaptogyrines ?\nLes infections prénatales peuvent-elles affecter les synaptogyrines ?\nLe stress environnemental est-il un facteur de risque ?\nLes facteurs nutritionnels influencent-ils les troubles des synaptogyrines ?",
"url": "https://questionsmedicales.fr/mesh/D062805?mesh_terms=Cardiovascular+System&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des synaptogyrines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests génétiques et des analyses de protéines neuronales."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer les synaptogyrines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie cérébrale et des biopsies peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils fiables pour les synaptogyrines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier des mutations spécifiques des synaptogyrines."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec les synaptogyrines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques, des convulsions ou des retards de développement peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les synaptogyrines par des analyses sanguines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les synaptogyrines sont principalement étudiées dans le tissu cérébral."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes associés aux dysfonctionnements des synaptogyrines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles de l'humeur, des problèmes de mémoire et des convulsions."
}
},
{
"@type": "Question",
"name": "Les troubles moteurs sont-ils liés aux synaptogyrines ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles moteurs peuvent survenir en raison de dysfonctionnements synaptiques."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs peuvent-ils être causés par des anomalies des synaptogyrines ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies peuvent entraîner des troubles cognitifs et des retards de développement."
}
},
{
"@type": "Question",
"name": "Les convulsions sont-elles fréquentes avec des problèmes de synaptogyrines ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les convulsions sont un symptôme courant des dysfonctionnements des synaptogyrines."
}
},
{
"@type": "Question",
"name": "Peut-on observer des changements de comportement liés aux synaptogyrines ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements de comportement peuvent être observés en cas de dysfonctionnement."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux synaptogyrines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de méthodes de prévention spécifiques pour ces troubles."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce est-il important pour les synaptogyrines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un dépistage précoce peut aider à gérer les symptômes et améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les conseils génétiques sont-ils recommandés pour les familles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conseils génétiques peuvent aider les familles à comprendre les risques de transmission."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à surveiller ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs environnementaux peuvent influencer la santé neurologique, mais peu sont connus."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles prévenir des troubles neurologiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui affectent le système nerveux."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles liés aux synaptogyrines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments anticonvulsivants et des thérapies comportementales."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option pour les anomalies des synaptogyrines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore largement disponible pour ces troubles."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils améliorer les symptômes liés aux synaptogyrines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent aider à gérer les symptômes neurologiques."
}
},
{
"@type": "Question",
"name": "Des interventions chirurgicales sont-elles possibles pour ces troubles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les interventions chirurgicales sont rares et réservées aux cas graves de convulsions."
}
},
{
"@type": "Question",
"name": "Les thérapies physiques sont-elles bénéfiques pour les patients ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les thérapies physiques peuvent aider à améliorer la motricité et la coordination."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des troubles des synaptogyrines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles cognitifs sévères et des problèmes de développement."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur sont-ils des complications possibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de l'humeur peuvent survenir en raison de dysfonctionnements synaptiques."
}
},
{
"@type": "Question",
"name": "Les patients peuvent-ils développer des troubles psychiatriques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles psychiatriques peuvent être associés à des anomalies des synaptogyrines."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent gravement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de mortalité avec ces troubles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles graves liés aux synaptogyrines peuvent augmenter le risque de mortalité."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles des synaptogyrines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs génétiques et environnementaux peuvent augmenter le risque de troubles."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans les troubles des synaptogyrines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles neurologiques peuvent être un facteur de risque."
}
},
{
"@type": "Question",
"name": "Les infections prénatales peuvent-elles affecter les synaptogyrines ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections prénatales peuvent influencer le développement neurologique."
}
},
{
"@type": "Question",
"name": "Le stress environnemental est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress environnemental peut contribuer à des troubles neurologiques chez certains individus."
}
},
{
"@type": "Question",
"name": "Les facteurs nutritionnels influencent-ils les troubles des synaptogyrines ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une nutrition inadéquate peut affecter le développement cérébral et synaptique."
}
}
]
}
]
}
Remnant cholesterol (RC) adversely contributes to cardiovascular disease (CVD) and overall survival in various diseases. However, its role in CVD outcomes and all-cause mortality in patients undergoin...
Based on lipid profiles recorded using standard laboratory procedures, fasting RC levels were calculated in 2710 incident patients undergoing PD who were enrolled between January 2006 and December 201...
An increased RC level was independently associated with all-cause and CVD mortality in patients undergoing PD, suggesting that RC was important clinically and required further research....
The pregnancy-related mortality rate in the United States is excessively high. The American Heart Association is dedicated to fighting heart disease and recognizes that cardiovascular disease, preexis...
Inflammation is gaining attention as a target for prevention of atherosclerotic cardiovascular disease (ASCVD). The purpose of this review is to compare the evidence for inflammation with the evidence...
Evidence from human genetic studies and randomized controlled trials implicate the inflammatory pathway from the inflammasome through interleukin (IL)-1 to IL-6 as a cause of ASCVD. Higher levels of I...
IL-6 mediated inflammation most likely causes ASCVD, in parallel with LDL cholesterol. However, fewer individuals in the general population are exposed to high IL-6 than high LDL cholesterol. For infl...
The risk of cardiovascular diseases has rapidly increased among middle-aged and elderly. However, little is known about the relationship of body composition changes with the risk of cardiovascular eve...
This study included 1048 participants (456 men [43.51%], aged 50-80 years) without overt cardiovascular disease, who underwent two examinations during 2013-2014 and 2015-2016. All participants were fo...
At baseline, the median body mass index (BMI), fat%, and FFM% were 23.9 (22.1-25.9) kg/m...
In a middle-aged and elderly community-based Chinese population, fat% gain or FFM% loss was associated with an increased risk of cardiovascular events....
Diabetes is associated with increased risk of certain cardiovascular diseases, yet the causality remains to be determined. Meanwhile, given that first-degree relatives share 50% of genes, the effect o...
Applying two-sample Mendelian randomization, we selected instruments for genetic predisposition to individual or familial diabetes based on published genome-wide association studies. The primary analy...
This study supports causal effects of not only individual but also familial diabetes on the development of cardiovascular diseases, which will help realize the potential effect of family history in th...
Atrial fibrillation is one of the most frequent cardiac arrhythmias in the industrialized world and ablation therapy is the method of choice for many patients. However, ablation scars alter the electr...
In this work, we present a simulation study analyzing five commonly used ablation scar patterns and their combinations in the left atrium regarding their impact on the pumping function of the heart us...
We found that systolic and diastolic function of the left atrium is impaired by ablation scars and that the reduction of atrial stroke volume of up to 11.43% depends linearly on the amount of inactiva...
This study provides biomechanical evidence that atrial ablation has acute effects not only on atrial contraction but also on ventricular performance. Therefore, the position and extent of ablation sca...
Inflammation plays an essential role in the pathogenesis of hypertension. A novel inflammatory biomarker systemic inflammatory response index (SIRI) is related with all-cause and cardiovascular (CVD) ...
A total of 21,506 participants with hypertension were recruited in the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018. SIRI was calculated as the neutrophil count...
During 189,063 person-years of follow-up, 5,680 (26.41%) death events were documented, including 1,967 (9.15%) CVD related deaths. A J-shaped association was observed between SIRI and all-cause and CV...
Elevated SIRI level is associated with increased all-cause and CVD mortality among patients with hypertension. SIRI is considered as a potential inflammatory biomarker in the clinical practice. Furthe...
Summarize selected late-breaking science on cardiovascular (CV) disease prevention presented at the 2022 scientific session of the American Heart Association (AHA)....
The PROMINENT trial compared pemafibrate to a placebo in patients with type 2 diabetes mellitus (DM) and mild-to-moderate hypertriglyceridemia and high-density lipoprotein cholesterol (HDL-C)<40 mg/dL...
The risk of cardiovascular diseases may be reduced by residing in green environments. However, there are relatively few longitudinal cohort studies, especially in Southeast Asia, that focused on the h...
The self-reported outcomes, including high blood pressure, high blood cholesterol, and diabetes, were reported in 2005, 2009, and 2013, where the study participants provided the exact year of disease ...
After adjusting for potential confounders, we observed that an IQR increase in NDVI was associated with lower incidence of high blood pressure (HR = 0.92, 95% CI: 0.89, 0.97) and high blood cholestero...
Long-term exposure to residential greenness was inversely associated with self-reported high blood pressure, high blood cholesterol, and diabetes in participants of TCS. Our study provides evidence th...
To investigate the individual and the joint effect of impaired fetal growth and adult health behaviors on the risk of cardiovascular diseases (CVDs)....
A total of 15,618 individuals were included from three sub-cohorts of the Stockholm Public Health Cohort. Data on participants' birthweight and gestational age were retrieved from the Medical Birth Re...
Individuals born small for gestational age (SGA) had a higher risk of CVDs than those born appropriate for gestational age (AGA), and the adjusted hazard ratio (HR) and 95% confidence interval (CI) wa...
Impaired fetal growth was associated with an increased risk of CVDs in adulthood, and the risk was highest in individuals with both impaired fetal growth and poor health behaviors in adulthood....